MarketCap
Facebook
X
Telegram
Natural Alternatives International Financial Ratios 2025-2010 | NAII
Brief overview of Natural Alternatives International's valuation and returns
The comparison uses the five latest available annual observations between 2018 and 2023.
Key multiples at the end of the period are P/E 14.67x (median 10.91x), EV/EBITDA 7.67x (median 6.07x), P/S 0.14x (median 0.34x). Valuation is roughly 40.5% below five-year reference levels. The discount may reflect opportunity or higher perceived risk.
Earnings yield calculated as 1/P/E is about 6.8%, showing current profit per unit of share price.
Returns on assets and capital are represented by ROE -19.8%, ROA -8.9%, ROCE -12.7%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
On PEG (0.14x), valuation is restrained relative to growth, but one ratio cannot replace cash-flow and risk analysis.
The cash cycle changed only slightly and ended at 76.2 days.
What the ratios show
Natural Alternatives International's multiples look low against history, but fundamental returns do not yet provide convincing support.
Annual Financial Ratios Natural Alternatives International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.4 | -5.4 | 14.7 | 6.8 | 7.0 | -28.7 | 10.9 | 13.3 | 9.1 | 7.3 | 12.1 | 18.3 | 21.4 | 11.1 | 6.7 | - |
P/S |
0.1 | 0.3 | 0.2 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | - |
EPS |
-2.3 | -1.2 | 0.4 | 1.8 | 1.7 | -0.2 | 1.0 | 0.8 | 1.1 | 1.5 | 0.5 | 0.3 | 0.2 | 0.6 | 0.7 | - |
EV (Enterprise Value) |
89.8 M | 107 M | 68.8 M | 108 M | 83.6 M | 65.6 M | 63.7 M | 60.7 M | 49.7 M | 70.2 M | 31.9 M | 26.9 M | 23.2 M | 39.2 M | 24.4 M | -8.55 M |
EBITDA per Share |
-0.69 | -0.66 | 1.53 | 2.92 | 2.86 | 0.366 | 1.38 | 1.87 | 1.84 | 2.15 | 0.976 | 0.833 | 0.755 | 1.32 | 0.78 | - |
EV/EBITDA |
-21.9 | -27.4 | 7.7 | 6.1 | 4.6 | 10.9 | 4.9 | 3.5 | 3.2 | 3.5 | 3.3 | 3.0 | 3.3 | 3.5 | 3.4 | - |
PEG |
-0.01 | -0.06 | 0.14 | 0.06 | 0.06 | 0.23 | 0.41 | -0.43 | -0.37 | 0.04 | 0.17 | 0.66 | -0.35 | -0.67 | 0.29 | - |
P/B |
0.3 | 0.5 | 0.4 | 0.8 | 0.9 | 0.7 | 0.9 | 1.0 | 1.1 | 1.3 | 0.9 | 0.9 | 0.8 | 1.2 | 1.0 | - |
P/CF |
3.1 | -25.9 | 5.3 | 6.1 | 3.6 | -55.6 | 57.7 | -30.0 | 7.5 | -60.2 | 41.8 | 13.7 | 11.8 | -87.6 | 4.6 | - |
ROE % |
-19.84 | -8.74 | 2.84 | 12.10 | 13.45 | -2.30 | 8.60 | 7.40 | 11.83 | 17.77 | 7.63 | 4.70 | 3.89 | 10.43 | 14.34 | - |
ROA % |
-8.93 | -4.45 | 1.88 | 7.34 | 8.95 | -1.37 | 7.00 | 5.93 | 9.96 | 12.87 | 6.22 | 3.82 | 3.37 | 8.81 | 12.36 | - |
ROCE % |
-12.66 | -10.33 | 5.31 | 15.45 | 17.07 | -1.63 | 7.52 | 13.44 | 15.56 | 22.30 | 9.30 | 6.51 | 5.29 | 15.36 | 6.42 | - |
Current Ratio |
1.8 | 2.0 | 3.0 | 2.5 | 3.0 | 2.8 | 5.0 | 4.6 | 5.0 | 2.9 | 4.8 | 4.3 | 5.9 | 5.0 | 5.6 | - |
DSO |
44.3 | 38.4 | 21.0 | 26.4 | 31.7 | 54.8 | 44.5 | 44.4 | 26.0 | 42.3 | 46.9 | 34.9 | 39.3 | 45.6 | 20.7 | - |
DIO |
74.3 | 92.1 | 83.5 | 77.3 | 67.8 | 102.1 | 82.7 | 81.1 | 52.3 | 85.2 | 70.4 | 76.6 | 71.8 | 53.2 | 52.4 | - |
DPO |
42.5 | 35.0 | 32.2 | 36.5 | 30.1 | 45.7 | 27.5 | 33.2 | 19.5 | 52.6 | 26.0 | 38.3 | 25.3 | 24.9 | 18.0 | - |
Operating Cycle |
118.7 | 130.4 | 104.5 | 103.7 | 99.5 | 156.9 | 127.2 | 125.5 | 78.3 | 127.5 | 117.2 | 111.4 | 111.1 | 98.8 | 73.2 | - |
Cash Conversion Cycle |
76.2 | 95.4 | 72.3 | 67.2 | 69.4 | 111.2 | 99.8 | 92.3 | 58.8 | 74.9 | 91.2 | 73.2 | 85.8 | 73.9 | 55.2 | - |
All numbers in USD currency
Quarterly Financial Ratios Natural Alternatives International
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.72 | -0.42 | -0.05 | -0.42 | -0.05 | - | -0.37 | -0.37 | -0.33 | - | -0.27 | -0.52 | -0.12 | - | -0.41 | 0.31 | 0.18 | 0.49 | 0.42 | 0.3 | 0.52 | 0.82 | 0.31 | 0.58 | 0.35 | 0.58 | 0.35 | 0.07 | 0.01 | 0.07 | 0.01 | 0.32 | 0.38 | 0.32 | 0.38 | -0.2 | 0.22 | -0.2 | 0.22 | 0.38 | 0.38 | 0.38 | 0.38 | 0.29 | 0.19 | 0.29 | 0.19 | 0.16 | 0.07 | 0.16 | 0.07 | 0.03 | 0.01 | 0.03 | 0.01 | 0.01 | 0.1 | 0.01 | 0.1 | 0.11 | 0.22 | 0.11 | 0.22 |
EBITDA per Share |
-0.47 | -0.11 | 0.24 | -0.11 | 0.24 | - | -0.17 | -0.28 | -0.12 | - | -0.15 | -0.4 | 0.1 | - | -0.26 | 0.61 | 0.42 | 0.99 | 0.75 | 0.56 | 0.85 | 1.41 | 0.44 | 0.86 | 0.47 | 1.2 | 0.47 | 0.1 | 0.13 | 0.39 | 0.13 | 0.32 | 0.52 | 0.56 | 0.52 | 0.34 | 0.39 | 0.57 | 0.39 | 0.47 | 0.61 | 0.64 | 0.61 | 0.42 | 0.34 | 0.57 | 0.34 | 0.2 | 0.17 | 0.38 | 0.17 | 0.04 | 0.13 | 0.26 | 0.13 | -0.04 | 0.26 | 0.18 | 0.26 | 0.18 | 0.45 | 0.4 | 0.45 |
ROE % |
-14.87 | -8.46 | -7.50 | -9.85 | -8.51 | -8.09 | -9.97 | -10.71 | -8.72 | -6.25 | -9.00 | -5.10 | -0.33 | 0.45 | 3.69 | 9.38 | 9.54 | 12.22 | 15.36 | 14.68 | 17.50 | 16.76 | 15.40 | 16.31 | 11.93 | 8.94 | 4.55 | 1.50 | 3.78 | 7.21 | 9.49 | 12.93 | 7.86 | 6.61 | 1.56 | 0.34 | 6.62 | 8.75 | 15.49 | 17.78 | 17.62 | 15.87 | 15.54 | 13.67 | 12.15 | 10.57 | 8.86 | 7.24 | 5.29 | 4.39 | 2.33 | 1.40 | 1.17 | 2.69 | 2.46 | 3.99 | 5.77 | 8.12 | 10.08 | 12.64 | 4.08 | 2.21 | 4.31 |
ROA % |
-6.30 | -3.70 | -3.45 | -4.66 | -4.23 | -4.04 | -5.07 | -5.63 | -4.66 | -3.43 | -5.09 | -2.77 | -0.09 | 0.34 | 2.30 | 5.80 | 5.97 | 7.72 | 10.00 | 9.75 | 11.19 | 10.49 | 9.26 | 9.55 | 7.09 | 5.42 | 2.81 | 1.02 | 2.93 | 5.69 | 7.83 | 10.75 | 6.84 | 5.78 | 1.40 | 0.37 | 5.32 | 6.86 | 12.00 | 13.38 | 13.07 | 11.89 | 12.04 | 10.94 | 9.96 | 8.76 | 7.36 | 6.03 | 4.35 | 3.60 | 1.94 | 1.20 | 1.02 | 2.37 | 2.17 | 3.46 | 4.96 | 6.66 | 8.36 | 10.24 | 3.24 | 1.91 | 3.36 |
ROCE % |
-11.46 | -4.69 | -4.67 | -8.60 | -8.13 | -8.54 | -10.86 | -12.23 | -9.33 | -7.04 | -9.92 | -4.82 | 1.01 | 1.62 | 6.17 | 12.89 | 12.96 | 16.25 | 19.97 | 19.32 | 23.91 | 21.79 | 20.95 | 20.68 | 14.16 | 11.21 | 4.69 | 1.69 | 3.71 | 7.57 | 9.59 | 13.45 | 14.27 | 13.52 | 14.31 | 13.60 | 15.04 | 18.32 | 20.38 | 23.88 | 24.48 | 22.00 | 22.44 | 19.80 | 17.12 | 14.58 | 11.60 | 9.00 | 6.55 | 5.47 | 2.87 | 1.75 | 0.41 | 2.75 | 1.41 | 3.76 | 7.63 | 11.35 | 15.49 | 19.52 | 6.27 | 3.46 | 6.62 |
Current Ratio |
1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 2.0 | 2.0 | 2.0 | 2.0 | 2.2 | 2.2 | 2.2 | 3.0 | 2.5 | 2.8 | 2.5 | 2.5 | 2.7 | 3.0 | 2.8 | 3.0 | 3.0 | 2.4 | 2.2 | 2.5 | 2.5 | 3.3 | 3.0 | 6.6 | 6.6 | 5.2 | 4.9 | 5.0 | 5.0 | 3.6 | 4.2 | 6.3 | 6.3 | 5.7 | 3.9 | 3.6 | 3.6 | 4.5 | 4.9 | 5.4 | 5.4 | 7.2 | 6.4 | 5.3 | 5.3 | 7.0 | 6.5 | 7.4 | 7.4 | 9.1 | 8.8 | 6.4 | 6.4 | 6.7 | 5.9 | 7.3 | 8.0 |
DSO |
35.2 | 41.3 | 38.1 | 41.3 | 34.8 | - | 45.3 | 46.2 | 47.5 | - | 39.4 | 36.6 | 22.5 | - | 25.0 | 23.9 | 31.0 | 18.2 | 34.2 | 42.7 | 40.8 | 19.2 | 34.5 | 34.4 | 37.4 | 28.9 | 35.9 | 43.9 | 46.4 | 50.0 | 46.1 | 33.2 | 34.2 | 18.4 | 39.5 | 30.2 | 28.6 | 12.5 | 33.1 | 33.5 | 34.5 | 39.5 | 27.8 | 28.7 | 40.7 | 33.5 | 30.9 | 30.9 | 35.9 | 33.5 | 30.4 | 38.3 | 39.3 | 36.6 | 26.4 | 35.4 | 44.5 | 58.4 | 37.8 | 32.6 | 24.7 | 18.6 | - |
DIO |
82.4 | 90.5 | 87.7 | 90.5 | 76.0 | - | 84.7 | 68.9 | 74.1 | - | 79.9 | 78.9 | 78.4 | - | 109.8 | 96.1 | 87.6 | 42.8 | 89.5 | 94.1 | 90.3 | 40.2 | 71.0 | 82.7 | 85.4 | 66.5 | 68.5 | 90.1 | 93.5 | 98.7 | 91.0 | 74.7 | 75.4 | 72.6 | 64.4 | 63.0 | 68.8 | - | 70.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
45.1 | 51.8 | 50.1 | 51.8 | 48.5 | - | 36.3 | 26.1 | 33.5 | - | 28.4 | 27.8 | 22.8 | - | 35.1 | 39.0 | 40.9 | 21.0 | 36.5 | 33.9 | 37.8 | 17.7 | 28.0 | 35.8 | 41.0 | 29.7 | 24.3 | 28.9 | 33.9 | 32.8 | 33.6 | 30.4 | 30.6 | 29.7 | 33.9 | 39.4 | 33.6 | - | 26.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 131.8 | 116.6 | - | 130.0 | 115.2 | 121.6 | - | 119.3 | 115.5 | 101.0 | - | 134.7 | 120.1 | 118.6 | 61.0 | 123.8 | 136.8 | 131.0 | 59.4 | 105.5 | 117.1 | 122.8 | 95.3 | 104.4 | 134.0 | 139.9 | 148.7 | 137.1 | 107.9 | 109.6 | 91.0 | 103.8 | 93.2 | 97.4 | 12.5 | 103.3 | 33.5 | 34.5 | 39.5 | 27.8 | 28.7 | 40.7 | 33.5 | 30.9 | 30.9 | 35.9 | 33.5 | 30.4 | 38.3 | 39.3 | 36.6 | 26.4 | 35.4 | 44.5 | 58.4 | 37.8 | 32.6 | 24.7 | 18.6 | - |
Cash Conversion Cycle |
- | - | - | 80.1 | 68.1 | - | 93.7 | 89.0 | 88.1 | - | 90.8 | 87.7 | 78.2 | - | 99.7 | 81.1 | 77.7 | 40.0 | 87.3 | 102.9 | 93.2 | 41.7 | 77.5 | 81.3 | 81.9 | 65.6 | 80.1 | 105.1 | 106.1 | 116.0 | 103.4 | 77.5 | 79.0 | 61.3 | 69.9 | 53.8 | 63.8 | 12.5 | 77.3 | 33.5 | 34.5 | 39.5 | 27.8 | 28.7 | 40.7 | 33.5 | 30.9 | 30.9 | 35.9 | 33.5 | 30.4 | 38.3 | 39.3 | 36.6 | 26.4 | 35.4 | 44.5 | 58.4 | 37.8 | 32.6 | 24.7 | 18.6 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Natural Alternatives International, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Russia
Canada
Brasil
China
Cayman-islands
